Adverse events following transarterial chemoembolization for hepatocellular carcinoma and factors predicting such events.

Tasneem, Abbas Ali; Abbas, Zaigham; Luck, Nasir Hassan; Hassan, Syed Mujahid; Faiq, Syed Muhammad

Tasneem, Abbas Ali; Abbas, Zaigham; Luck, Nasir Hassan; Hassan, Syed Mujahid; Faiq, Syed Muhammad.

Affiliation

Tasneem AA; Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation (SLUT), Karachi, Pakistan. draayt@yahoo.com

J Pak Med Assoc ; 63(2): 239-44, 2013 Feb.

Article in En | MEDLINE | ID: mdl-23894903

Subject(s)

Antineoplastic Agents/administration & dosage; Carcinoma, Hepatocellular/therapy; Chemoembolization, Therapeutic/adverse effects; Ethiodized Oil/administration & dosage; Liver Neoplasms/therapy; Adult; Aged; Carcinoma, Hepatocellular/complications; Carcinoma, Hepatocellular/pathology; Female; Humans; Liver Cirrhosis/complications; Liver Neoplasms/complications; Liver Neoplasms/pathology; Male; Middle Aged; Tumor Burden

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Chemoembolization, Therapeutic / Ethiodized Oil / Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Pak Med Assoc Year: 2013 Type: Article Affiliation country: Pakistan

Search on Google

Add to My VHL

XML

PubMed Links